Prolonged treatment of Zollinger-Ellison syndrome by long-acting somatostatin

Lancet. 1986 Mar 8;1(8480):554-5. doi: 10.1016/s0140-6736(86)90905-0.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Female
  • Humans
  • Middle Aged
  • Octreotide
  • Somatostatin / analogs & derivatives*
  • Somatostatin / therapeutic use
  • Time Factors
  • Zollinger-Ellison Syndrome / drug therapy*

Substances

  • Somatostatin
  • Octreotide